New selective PAD4 inhibitors binding a calcium-deficient method of the PAD4 enzyme have validated the important enzymatic part of human and mouse PAD4 in both of those histone citrullination and neutrophil extracellular trap formation for, to our understanding, The very first time. The therapeutic potential of PAD4 inhibitors can now https://joshq050esd2.blogdun.com/profile